Physician profile
Nelson Wong
NPI 1013982685
$5,240.64
in general payments reported to CMS, 2019-2025
37 companies · $507 in 2025
The $507 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $1,070 · 2021: $713 · 2022: $693 · 2023: $748 · 2024: $569 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $964.34 | 2019-2022 | |
| Abbvie INC. | $680.93 | 2022-2025 | Botox |
| Scilex Pharmaceuticals INC. | $642.31 | 2019-2023 | Ztlido |
| Fidia Pharma USA INC. | $436.84 | 2020-2023 | Triluron, Hymovis |
| Medtronic, INC. | $338.13 | 2021-2024 | Intellis Adaptivestim |
| Ferring Pharmaceuticals INC. | $226.20 | 2019-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $177.74 | 2019-2024 | Orthovisc, Monovisc |
| Si-Bone, INC. | $159.02 | 2019-2025 | |
| Boston Scientific Corporation | $157.87 | 2024-2025 | General - Pain Management |
| Ipsen Biopharmaceuticals, INC | $151.99 | 2023-2025 | Dysport |
| Avanir Pharmaceuticals, INC. | $128.26 | 2022 | |
| 180 Medical, INC. | $124.99 | 2019-2022 | |
| Pfizer INC. | $124.96 | 2024-2025 | |
| Amneal Pharmaceuticals LLC | $83.90 | 2023 | Lyvispah |
| Horizon Therapeutics Plc | $83.84 | 2020-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $79.80 | 2023-2024 | Xtampza, Belbuca |
| Sanofi-Aventis U.S. LLC | $70.37 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.68 | 2019-2025 | Relistor |
| Lundbeck LLC | $53.20 | 2023-2025 | Vyepti |
| Ibsa Pharma INC. | $40.29 | 2021 | |
| Metacel Pharmaceuticals LLC | $39.99 | 2022-2023 | Ozobax |
| Biogen, INC. | $39.81 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $38.64 | 2019 | |
| Biodelivery Sciences International, INC. | $35.34 | 2021 | |
| Seapearl East, INC | $35.34 | 2022 | |
| Medtronic USA, INC. | $32.85 | 2019 | |
| Abbott Laboratories | $31.35 | 2019 | |
| Arbor Pharmaceuticals, INC. | $27.88 | 2021 | |
| Abc Home Medical Supply, INC. | $25.21 | 2024 | |
| Hollister Incorporated | $25.21 | 2024 | Vapro Plus Pocket |
| Pacira Therapeutics, INC. | $22.35 | 2020 | |
| Assertio Therapeutics, INC. | $20.98 | 2019 | |
| Antares Pharma, INC. | $18.43 | 2020 | |
| Grt US Holding, INC. | $17.41 | 2020 | |
| Lilly USA, LLC | $17.39 | 2019 | |
| Smith+Nephew, INC. | $16.04 | 2020 | |
| Coloplast Corp | $12.76 | 2023 | Speedicath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.